Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nu-Med Plus (NUMD) EPS (Basic) (2016 - 2025)

Nu-Med Plus' EPS (Basic) history spans 10 years, with the latest figure at -$0.0 for Q4 2021.

  • On a quarterly basis, EPS (Basic) rose 84.69% to -$0.0 in Q4 2021 year-over-year; TTM through Dec 2021 was -$0.01, a 71.72% increase, with the full-year FY2021 number at -$0.01, up 75.0% from a year prior.
  • EPS (Basic) hit -$0.0 in Q4 2021 for Nu-Med Plus, down from -$0.0 in the prior quarter.
  • Over the last five years, EPS (Basic) for NUMD hit a ceiling of $0.11 in Q1 2017 and a floor of -$0.02 in Q2 2020.
  • Historically, EPS (Basic) has averaged $0.01 across 5 years, with a median of -$0.0 in 2018.
  • Biggest five-year swings in EPS (Basic): skyrocketed 1141.35% in 2017 and later plummeted 263.67% in 2020.
  • Tracing NUMD's EPS (Basic) over 5 years: stood at $0.1 in 2017, then plummeted by 109.6% to -$0.01 in 2018, then skyrocketed by 53.92% to -$0.0 in 2019, then crashed by 117.01% to -$0.01 in 2020, then skyrocketed by 84.69% to -$0.0 in 2021.
  • Business Quant data shows EPS (Basic) for NUMD at -$0.0 in Q4 2021, -$0.0 in Q3 2021, and -$0.0 in Q2 2021.